Literature DB >> 21787784

Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block.

Olivier Bignolais1, Khai Le Quang, Patrice Naud, Aziza El Harchi, François Briec, Julien Piron, Anne Bourge, Anne-Laure Leoni, Flavien Charpentier, Sophie Demolombe.   

Abstract

Complete atrioventricular block (CAVB) and related ventricular bradycardia are known to induce ventricular hypertrophy and arrhythmias. Different animal models of CAVB have been established with the most common being the dog model. Related studies were mainly focused on the consequences on the main repolarizing currents in these species, i.e. IKr and IKs, with a limited time point kinetics post-AVB. In order to explore at a genomic scale the electrical remodeling induced by AVB and its chronology, we have developed a novel model of CAVB in the mouse using a radiofrequency-mediated ablation procedure. We investigated transcriptional changes in ion channels and contractile proteins in the left ventricles as a function of time (12h, 1, 2 and 5 days after CAVB), using high-throughput real-time RT-PCR. ECG in conscious and anesthetized mice, left ventricular pressure recordings and patch-clamp were used for characterization of this new mouse model. As expected, CAVB was associated with a lengthening of the QT interval. Moreover, polymorphic ventricular tachycardia was recorded in 6/9 freely-moving mice during the first 24h post-ablation. Remarkably, myocardial hypertrophy was only evident 48 h post-ablation and was associated with increased heart weight and altered expression of contractile proteins. During the first 24 hours post-CAVB, genes encoding ion channel subunits were either up-regulated (such as Nav1.5, +74%) or down-regulated (Kv4.2, -43%; KChIP2, -47%; Navβ1, -31%; Cx43, -29%). Consistent with the transient alteration of Kv4.2 expression, I(to) was reduced at day 1, but restored at day 5. In conclusion, CAVB induces two waves of molecular remodeling: an early one (≤24 h) leading to arrhythmias, a later one related to hypertrophy. These results provide new molecular basis for ventricular tachycardia induced by AV block.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787784     DOI: 10.1016/j.yjmcc.2011.07.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse.

Authors:  Maarten Hulsmans; Aaron D Aguirre; Matthew D Bonner; Aneesh Bapat; Sebastian Cremer; Yoshiko Iwamoto; Kevin R King; Filip K Swirski; David J Milan; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

Review 2.  Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.

Authors:  Jeanne M Nerbonne
Journal:  Curr Opin Pharmacol       Date:  2014-03-13       Impact factor: 5.547

Review 3.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

4.  Effects of IGF-1 on I(K) and I(K1) Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes.

Authors:  Richard M Millis; Zikiar V Alvin; Aiqiu Zhao; Georges E Haddad
Journal:  Int J Cell Biol       Date:  2012-06-18

Review 5.  Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models.

Authors:  Lois Choy; Jie Ming Yeo; Vivian Tse; Shing Po Chan; Gary Tse
Journal:  Int J Cardiol Heart Vasc       Date:  2016-09

6.  A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure.

Authors:  Marc Santolini; Milagros C Romay; Clara L Yukhtman; Christoph D Rau; Shuxun Ren; Jeffrey J Saucerman; Jessica J Wang; James N Weiss; Yibin Wang; Aldons J Lusis; Alain Karma
Journal:  NPJ Syst Biol Appl       Date:  2018-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.